share_log

Zevra Therapeutics Says Arimoclomol Research Featured In Two Poster Presentations At 19th Annual WORLDSymposium 2023

Zevra Therapeutics Says Arimoclomol Research Featured In Two Poster Presentations At 19th Annual WORLDSymposium 2023

Zevra 治療說,阿里莫洛莫爾研究在第 19 屆年度世界研討會上的兩個海報演講中特色 2023
Benzinga ·  2023/02/24 07:37

Interim data analysis of four-year, open-label extension from Phase 2/3 clinical trial suggests arimoclomol may reduce long-term progression of Niemann-Pick Disease Type C (NPC)

2/3期臨床試驗四年開放標籤延期的中期數據分析表明,阿利莫洛爾可能會減緩C型尼曼-皮克病(NPC)的長期進展

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論